Navigation Links
Schizophrenia linked to signaling problems in new brain study
Date:3/3/2009

Schizophrenia could be caused by faulty signalling in the brain, according to new research published today in the journal Molecular Psychiatry. In the biggest study of its kind, scientists looking in detail at brain samples donated by people with the condition have identified 49 genes that work differently in the brains of schizophrenia patients compared to controls.

Many of these genes are involved in controlling cell-to-cell signalling in the brain. The study, which was carried out by researchers at Imperial College London and GlaxoSmithKline, supports the theory that abnormalities in the way in which cells 'talk' to each other are involved in the disease.

Schizophrenia is thought to affect around one in 100 people. Symptoms vary but can include hallucinations, lack of motivation and impaired social functioning. The disorder has little physical effect on the brain and its causes are largely unknown.

Some scientists believe that schizophrenia could be caused by the brain producing too much dopamine, partly because drugs that block dopamine action provide an effective treatment for the condition. Another theory is that the coat surrounding nerve cells, which is made of myelin, is damaged in people with schizophrenia. However, the new study found that the genes for dopamine and for myelin were not acting any differently in schizophrenia patients compared with controls.

Professor Jackie de Belleroche, the corresponding author of the paper from Imperial College London said: "The first step towards better treatments for schizophrenia is to really understand what is going on, to find out what genes are involved and what they are doing. Our new study has narrowed the search for potential targets for treatment."

As well as pointing towards signalling as the cause of schizophrenia, the new findings could also lead to new ways of diagnosing the condition. At the moment, patients are diagnosed on the basis of their behaviour.

"Most patients are diagnosed as teenagers or in their early 20s, but if they could be diagnosed earlier, they could be treated more effectively and they could have a better quality of life. To have the possibility of transforming someone's life early on instead of having to take drugs indefinitely would be wonderful," added Professor de Belleroche.

The researchers reached their conclusions after analysing brain tissue from 23 controls and 28 schizophrenia patients, selected from brains donated by UK patients being treated for schizophrenia and comparing the data to an equivalent study in the USA. The changes described in this study were common to both studies. This is the biggest cohort of schizophrenia patients used for this type of study to date.

This is part of a larger study looking at proteins and DNA as well as mRNA in the samples, which were taken from two brain regions associated with schizophrenia: the frontal cortical area and the temporal cortex. mRNA are copies of small sections of our DNA that cells use to build proteins. Unlike DNA, mRNA varies in different parts of the body, where different proteins are needed.


'/>"/>

Contact: Lucy Goodchild
lucy.goodchild@imperial.ac.uk
44-020-759-46712
Imperial College London
Source:Eurekalert

Related medicine news :

1. A Drug That Receives Regulatory Approval for Cognitive Impairment Associated With Schizophrenia Would Earn a Higher Patient Share in the United States Than in Europe
2. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
3. Genome Study Points to New Culprit for Schizophrenia
4. Johns Hopkins researchers discover new schizophrenia gene
5. Altered brain activity in schizophrenia may cause exaggerated focus on self
6. People With Schizophrenia Say Bias Is Part of Their Lives
7. Common Genes Link Bipolar Disorder, Schizophrenia
8. Compound Tied to Cognitive Deficits in Schizophrenia
9. Glutamate: Too much of a good thing in schizophrenia?
10. Anti-inflammatory medications may become a treatment for schizophrenia
11. New candidate genes for schizophrenia identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Thousand Oaks, CA (PRWEB) , ... April 28, 2016 , ... ... brand is currently number one in Central America and is looking to grow their ... provide marketing for such an exceptional brand as La Sirena Foods and ...
(Date:4/28/2016)... ... April 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, ... The competition will be held at the University of Montana on April 28-May 1. ... the Mississippi River. , In order to qualify, Varize needed to place top seven ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... open availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. ... This innovative standard will make it possible to build applications that generate ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online plastic surgery ... The forum section was recently revamped and upgraded to allow even more interaction between ... across the country. , According to the senior editor of Cosmetic Town, “We are ...
(Date:4/28/2016)... Beach, FL (PRWEB) , ... April 28, 2016 , ... ... the spring season. Smart pots are frequently used by professional organic farmers and nurseries ... growers to order their supply of fabric pots. Our goal is to offer wholesale ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016 ... the  "Global Anesthesia Disposables Market 2016-2020"  report ... ) ,The global anesthesia disposables market ... of 4.03% during the period 2016-2020.  ... threat to patients, safety. Organizations like the ...
(Date:4/27/2016)... April 27, 2016 Global  ... 2.14 billion by 2022, according to a new ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... the efficiency and accuracy delivered by the new ... for novel urinalysis instruments and consumables. For instance, ...
(Date:4/27/2016)... 2016 At the Sachs CEO ... a Phase 2 clinical study of its lead drug ... cochlear implantation (CI) surgery. This large, placebo-controlled, double-blind, phase ... Germany and France . ... the time of surgery. "Despite advances in cochlear implant ...
Breaking Medicine Technology: